Publicité
Publicité

AB4AD

Rang #6442
AB4AD (Antibodies for Alzheimer's Disease) logo

AB4AD (Antibodies for Alzheimer's Disease)

0.11663
-0.00515483695
-4.23%
01 févr., 08:31 UTC

About

Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).

Informations et liens

Contrats

  • base:
    0x574…9e2d0
En savoir plus
Données provenant de

Monnaies tendance

bitcoin logoBitcoin$75,250.03
-4.19%
pax-gold logoPAX Gold$4,578.84
-6.19%
tether-gold logoTether Gold$4,540.64
-6.28%
solana logoSolana$97.87
-6.51%
canton-network logoCanton$0.18361
+3.42%
ripple logoXRP$1.54
-7.00%
ethereum logoEthereum$2,188.87
-9.92%
pepe logoPepe$0.00000403693
-3.92%
hyperliquid logoHyperliquid$30.62
-0.46%
lighter logoLighter$1.55
-3.44%
Publicité